Jinghao Sheng Selected Research

ribonuclease 4

1/2022	Ribonuclease 4 is associated with aggressiveness and progression of prostate cancer.
5/2014	Transcription of angiogenin and ribonuclease 4 is regulated by RNA polymerase III elements and a CCCTC binding factor (CTCF)-dependent intragenic chromatin loop.
4/2013	Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinghao Sheng Research Topics

Disease

7	Neoplasms (Cancer) 03/2022 - 11/2010
3	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 01/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 05/2014
2	Inflammation (Inflammations) 03/2022 - 11/2021
2	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2013
2	Colitis 01/2021 - 01/2020
2	Carcinogenesis 01/2021 - 01/2020
2	Pathologic Processes 05/2018 - 05/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 06/2014
1	Non-alcoholic Fatty Liver Disease 03/2022
1	Hyperplasia 01/2022
1	Adenoma (Adenomas) 01/2021
1	Dysbiosis 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Insulin Resistance 01/2018
1	Obesity 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2015
1	Starvation 01/2014
1	Melanoma (Melanoma, Malignant) 07/2013
1	Weight Loss (Weight Reduction) 04/2013
1	Nerve Degeneration 04/2013
1	Hypoxia (Hypoxemia) 11/2010

Drug/Important Bio-Agent (IBA)

9	angiogeninIBA 03/2022 - 10/2013
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
4	Ribonucleases (Ribonuclease)IBA 11/2021 - 10/2013
3	ribonuclease 4IBA 01/2022 - 04/2013
3	Transfer RNA (tRNA)IBA 11/2021 - 05/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 11/2010
2	Pancreatic Ribonuclease (Ribonuclease A)IBA 03/2022 - 01/2019
2	Ribosomal DNA (rDNA)IBA 01/2021 - 10/2013
2	ProgranulinsIBA 01/2015 - 06/2014
2	FollistatinIBA 01/2014 - 11/2010
1	CadmiumIBA 03/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2022
1	LipidsIBA 03/2022
1	MetalsIBA 03/2022
1	Angiogenic ProteinsIBA 03/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	CateninsIBA 01/2020
1	Val Transfer RNAIBA 01/2019
1	Cyclin-Dependent Kinase 6IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Ribosomal RNAIBA 10/2013
1	AndrogensIBA 10/2013
1	Androgen Receptors (Androgen Receptor)IBA 10/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2013

Therapy/Procedure

1	Transplantation 01/2021
1	Oral Administration 01/2021
1	Castration 10/2013
1	Therapeutics 10/2013